New Delhi: The government of India has decided to set up two more laboratories to augment the need for vaccine testing in the country following the covid-19 pandemic that is devastating the country.
Currently, the nation has a Central Drugs Laboratory (CDL) at Kasauli, which is the National Control Laboratory for testing and pre-release certification of Immunobiologicals (vaccines and antisera) meant for human use in India.
Department of Biotechnology, Ministry of Science & Technology ,Government of India has set up the new testing facilities in its Autonomous Research Institutes National Centre for Cell Science (NCCS), Pune, and National Institute of Animal Biotechnology,(NIAB) Hyderabad as Central Drug Laboratory (CDL), for batch testing and quality control of vaccines.
Accordingly, two new vaccine testing facilities have been set up as Central Drug laboratories at DBT- NCCS, and DBT-NIAB. The new facilitate would expedite testing / pre-release certification of the vaccines.
The facility at NCCS, Pune, has now been notified as Central Drugs Laboratory for testing and lot release of COVID-19 vaccines vide. Gazette notification issued by Ministry of Health & Family Welfare on 28th June 2021.The facility at NIAB ,Hyderabad is likely to receive necessary notification shortly.
Both the institutions through relentless efforts have set up the state-of-the-art modern facilities for this purpose. The facilities are expected to test approx 60 batches of vaccines per month, and are also geared up to test existing COVID-19 vaccines and other newer COVID-19 vaccines as per demand of the Nation. This will not only expedite the Vaccine manufacture and supply but also be logistically convenient considering that both Pune and Hyderabad are the two Vaccine manufacturing hubs